Drug Makers Disagree on Overdose Antidote

Drug Makers Disagree on Overdose Antidote
AP Photo/Mel Evans, File

A meeting on Wednesday between the Food and Drug Administration and pharmaceutical companies that make the anti-overdose, life-saving medication naloxone could alter the drug's pricing as well as how available it will be to the general public. 


The drug is increasingly being used in communities to counter an epidemic of opioid use and tens of thousands of deaths from potent painkillers and tranquilizers like fentanyl and carfentanil, but health officials have called for greater competition among manufacturers in an effort to make it more affordable. The drug cost $1 a dose a decade ago and $40 a dose today.



Comment
Show comments Hide Comments


Related Articles